Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
4SCAR19/22 and IL-2 in Pediatric B-Cell Malignancies
NCT03098355Phase 2Withdrawn
- Sponsor
- Southern Medical University Zhujiang Hospital
- Start
- Dec 2017
- Primary completion
- Dec 2022
- Modality
- CAR-T Cells
- Countries
- 1
01
Overview
A Phase 2 trial of 4SCAR19 + 4SCAR22 in B cell acute lymphoblastic leukemia (B-ALL), B-cell non-Hodgkin lymphoma, sponsored by Southern Medical University Zhujiang Hospital. Planned start Dec 2017; status: withdrawn.
02
Drugs
4SCAR19 + 4SCAR22
03
Conditions
B cell acute lymphoblastic leukemia (B-ALL)B-cell non-Hodgkin lymphoma
Beyond the preview
Go deeper on NCT03098355.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03098355.